How to predict off-target adverse drug reactions (ADRs)
The Safety Margin Tool helps predict and mitigate ADRs by leveraging curated preclinical and clinical data to identify off-target effects early. Developed in partnership with Novartis, the tool:
- Enables comparative safety profiling across compounds to inform lead selection and optimization 
- Provides mechanistic insight into adverse events, including those related to polypharmacy 
- Supports dosing strategy optimization to improve therapeutic safety and reduce the risk of late-stage failures 

